With industrial sites in Spain, Mexico, and China, Esteve covers the contract manufacturing (CMO) business.

The company's product portfolio includes drugs for the treatment of serious diseases in therapeutic areas such as oncology and pain, the central nervous system, ophthalmology, neurology, and dermatology.

The company's origins date back to 1929, when Dr. Antoni Esteve i Subirana, researcher and entrepreneur, founded the firm.

The acquisition strengthens Esteve's portfolio with key drugs targeting conditions such as Cushing's syndrome and adrenocortical carcinoma, boosting their presence in Europe and the U.S. [6] Expansion in Girona (2024): In 2024, Esteve Pharmaceuticals began the construction of a new manufacturing unit at its Girona plant to enhance its production of active pharmaceutical ingredients (APIs).

[8] In the chemical field, the company focuses on the development of new processes, production and commercialization of active pharmaceutical ingredients.